What You Should Know:
- Mayo Clinic Platform has launched a multiyear pathway program within its Accelerate initiative, announcing an inaugural cohort of 12 health technology companies focused on artificial intelligence across care delivery and enterprise operations.
- Since its launch in 2022, Mayo Clinic Platform Accelerate has supported over 130 portfolio companies globally, historically leaning on structured 30-week tracks.
- The new multiyear pathway expands that
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Hinge Health Completes $105M Cash Acquisition of Virtual Digestive Health Leader Cylinder Health
What You Should Know
Digital health leader Hinge Health completed the acquisition of virtual-first digestive healthcare company Cylinder Health for $105M in cash consideration.The transaction delivers an exit for early healthcare venture backer 7wire Ventures, which initially invested in Cylinder in 2021 and supported its leadership development, clinical roadmap, and commercial scaling.Cylinder brings an established enterprise footprint: nearly 100 enterprise clients representing
Read More
Thyme Care Secures Over $125M, Launches Thyme Companies to Scale Oncology Innovation
What You Should Know
Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M, led by Morgan Health.Strategic and institutional syndication includes major national payers and healthcare venture firms: Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.The company manages more than $7Bin annual oncology spend, with
Read More
Elucid Raises $55M to Expand Non-Invasive Cardiovascular Diagnostic Platform
What You Should Know
Boston-based cardiovascular medtech innovator Elucid closed an oversubscribed $55M Series D financing round, bringing its cumulative funding to approximately $185M.The round features participation from a new major, publicly traded medical device company—becoming Elucid’s fourth publicly traded strategic backer—alongside existing investors including IAG Capital Partners and Elevage Medical Technologies (a Patient Square Capital platform).Proceeds will accelerate the
Read More
M&A: Cureety Acquires Reimagine Care to Expand Precision Oncology Platform Across 250 Cancer Centers
What You Should Know
Paris-based precision oncology company Cureety has acquired Nashville-based Reimagine Care, uniting therapy-specific remote clinical intelligence with conversational AI patient engagement and specialized human care teams.The combined entity operates as a profitable organization serving more than 250 cancer centers and 100,000 patients across five countries, with a joint workforce of approximately 150 employees.Integrates Reimagine Care’s conversational AI platform, Remi,
Read More
LeanTaaS Acquires Care Transition Platform Aidin to Expand iQueue for Inpatient Flow
What You Should Know
Healthcare capacity management and predictive operational software market leader LeanTaaS has acquired Aidin, a specialized care transition platform.Integrates Aidin’s network—which serves 200+ hospitals across ~20 health systems and coordinates more than 2 million referrals annually across 21,000+ post-acute providers—directly into LeanTaaS’ iQueue for Inpatient Flow.The acquisition expands LeanTaaS’ market footprint, currently deployed across 200 health systems in
Read More
The Next Phase of AgeTech: Integration Will Define the Future
AgeTech is reaching an inflection point—but not for the reasons expected.
Investment in technologies designed to support aging adults has surged, fueled by a rapidly expanding industry projected to be a $120 billion market by 2030, drawing in Big Tech, startups, and legacy healthcare companies alike — all racing to enable seniors to live safely, independently, and with dignity at home.
Yet despite this momentum, more technology is not
Read More
N-Power Medicine Closes $32M to Expand Community Oncology Research
What You Should Know
Oncology drug development platform N-Power Medicine closed a $32M Series B financing round to scale its community oncology clinical research network and expand adoption of its Prospective External Control Arms (ProECA) technology.The financing features Labcorp Venture Fund as a new strategic investor, alongside continued participation from Merck Global Health Innovation Fund (Merck GHI), Innovatus Capital Partners, and a leading U.S.-based biotechnology investor.Solves a
Read More
BARDA Awards Flosonics Medical Up to $70M to Expand Wearable Ultrasound into Trauma Care
What You Should Know
Flosonics Medical secured a major development contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).Awarded under BARDA’s Burn and Blast Medical Countermeasures program (Contract No. 75A50126C00006), the agreement includes initial funding of approximately $15 million, with a total potential value of up to ~$70
Read More
Glooko Launches GestationalCare to Unify Multi-Device Diabetes Telemetry in High-Risk Pregnancy
What You Should Know
Global connected diabetes care leader Glooko, Inc. announced GestationalCare™, a dedicated pregnancy-specific clinical module built on its ambulatory diabetes management platform.GestationalCare resolves the acute challenge of compressed clinical timelines in pregnancy, replacing disconnected spreadsheets, patient portal screenshots, and paper logs with automated, device-neutral data aggregation.Covers the full spectrum of maternal metabolic care: Gestational Diabetes
Read More
